Nitric oxide: Inhibitory effects on endothelial cell calcium signaling, prostaglandin I2 production and nitric oxide synthase expression

Cardiovascular Research

Volumn 62, Issue 1, 2004, Pages 194-201

  Takeuchi, Kazuhiko ^a   Watanabe, Hiroshi ^a   Tran, Quang Kim ^a   Ozeki, Mariko ^a   Sumi, Daigo ^b   Hayashi, Toshio ^b   Iguchi, Akihisa ^b   Ignarro, Louis J ^c   Ohashi, Kyoichi ^a   Hayashi, Hideharu ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Calcium (cellular); Endothelial function; Nitric oxide; Prostaglandins

Indexed keywords

2 (4 CARBOXYPHENYL) 4,4,5,5 TETRAMETHYLIMIDAZOLINE 1 OXYL 3 OXIDE; 3,3 BIS(2 AMINOETHYL) 1 HYDROXY 2 OXOTRIAZENE; 8 BROMO CYCLIC GMP; BRADYKININ; CALCIUM; CYCLIC GMP; ENDOTHELIUM DERIVED RELAXING FACTOR; FURA 2 ACETOXYMETHYL ESTER; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE; PROSTACYCLIN; SCAVENGER; SPERMINE; THAPSIGARGIN;

ANIMAL CELL; AORTA; ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CELL FUNCTION; CELL LEVEL; CELL STIMULATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME IMMUNOASSAY; HALF LIFE TIME; INCUBATION TIME; MEASUREMENT; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; WESTERN BLOTTING;

ANIMALS; BRADYKININ; CALCIUM SIGNALING; CALCIUM-TRANSPORTING ATPASES; CYCLIC GMP; DEPRESSION, CHEMICAL; ENDOTHELIAL CELLS; EPOPROSTENOL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; SWINE; THAPSIGARGIN;

EID: 12144290434     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2003.12.028     Document Type: Article

References (39)

1. Kubes P., Suzuki M., Granger D.N. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc. Natl. Acad. Sci. U. S. A. 88:1991;4651-4655.
2. Radomski M.W., Palmer R.M., Moncada S. The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br. J. Pharmacol. 92:1987;639-646.
3. Garg U.C., Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J. Clin. Invest. 83:1989;1774-1777.
4. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6:1992;3051-3064.
5. Lowenstein C.J., Snyder S.H. Nitric oxide, a novel biologic messenger. Cell. 70:1992;705-707.
6. Moncada S., Higgs E.A. Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J. 9:1995;1319-1330.
7. 2+ influx. J. Biol. Chem. 269:1994;12645-12653.
8. 2+ entry in rat pancreatic acinar cells. J. Biochem. 311:1995;649-656.
9. Watanabe H., Kuhne W., Spahr R., Schwartz P., Piper H.M. Macromolecule permeability of coronary and aortic endothelial monolayers under energy depletion. Am. J. Physiol. 260:1991;H1344-H1352.
10. Ishii K., Sheng H., Warner T.D., Forstermann U., Murad F. A simple and sensitive bioassay method for detection of EDRF with RFL-6 rat lung fibroblasts. Am. J. Physiol. 261:1991;H598-H603.
11. Kibira S., Dudek R., Narayan K.S., Bing R.J. Release of prostacyclin, endothelium-derived relaxing factor and endothelin by freshly harvested cells attached to microcarrier beads. Mol. Cell. Biochem. 108:1991;75-84.
12. Gerritsen M.E. Eicosanoid production by the coronary microvascular endothelium. Fed. Proc. 46:1987;47-53.
13. Jaffe E.A., Grulich J., Weksler B.B., Hampel G., Watanabe K. Correlation between thrombin-induced prostacyclin production and inositol trisphosphate and cytosolic free calcium levels in cultured human endothelial cells. J. Biol. Chem. 262:1987;8557-8565.
14. Oriji G.K. Cyclosporine A-induced prostacyclin release is maintained by extracellular calcium in rat aortic endothelial cells: role of protein kinase C. Prostaglandins, Leukot. Essent. Fat. Acids. 61:1999;119-123.
15. Tran Q.K., Ohashi K., Watanabe H. Calcium signaling in endothelial cells. Cardiovasc. Res. 48:2000;13-22.
16. 2+ release and influx responses in PC12-64 cells. Eur. J. Pharmacol. 289:1995;113-123.
17. Kwan H.Y., Huang Y., Yao X. Store-operated calcium entry in vascular endothelial cells is inhibited by cGMP via a protein kinase G-dependent mechanism. J. Biol. Chem. 275:2000;6758-6763.
18. Li H., Brodsky S., Basco M., Romanov V., De Angelis D.A., Goligorsky M.S. Nitric oxide attenuates signal transduction: possible role in dissociating caveolin-1 scaffold. Circ. Res. 88:2001;229-236.
19. 2+ uptake in bovine vascular endothelial cells. J. Physiol. 539:2002;77-91.
20. Dinerman J.L., Lawson D.L., Mehta J.L. Interactions between nitroglycerin and endothelium in vascular smooth muscle relaxation. Am. J. Physiol. 260:1991;H698-H701.
21. 2+ entry in human and bovine endothelial cells. J. Physiol. 482:1995;259-274.
22. Cassoly R., Gibson Q. Conformation, co-operativity and ligand binding in human hemoglobin. J. Mol. Biol. 91:1975;301-313.
23. Khatsenko O.G., Gross S.S., Rifkind A.B., Vane J.R. Nitric oxide is a mediator of the decrease in cytochrome P450-dependent metabolism caused by immunostimulants. Proc. Natl. Acad. Sci. U. S. A. 90:1993;11147-11151.
24. Stadler J., Trockfeld J., Schmalix W.A., Brill T., Siewert J.R., Greim H.et al. Inhibition of cytochromes P4501A by nitric oxide. Proc. Natl. Acad. Sci. U. S. A. 91:1994;3559-3563.
25. Wink D.A., Osawa Y., Darbyshire J.F., Jones C.R., Eshenaur S.C., Nims R.W. Inhibition of cytochromes P450 by nitric oxide and a nitric oxide-releasing agent. Arch. Biochem. Biophys. 300:1993;115-123.
26. 2+ signaling in vascular endothelial cells. Am. J. Physiol. 270:1996;L954-L961.
27. Cassina A., Radi R. Differential inhibitory action of nitric oxide and peroxynitrite on mitochondrial electron transport. Arch. Biochem. Biophys. 328:1996;309-316.
28. Poderoso J.J., Carreras M.C., Lisdero C., Riobo N., Schopfer F., Boveris A. Nitric oxide inhibits electron transfer and increases superoxide radical production in rat heart mitochondria and submitochondrial particles. Arch. Biochem. Biophys. 328:1996;85-92.
29. 2+/calmodulin-regulated nitric oxide synthases. Cell Calcium. 13:1992;427-434.
30. 2+ influx. Biochem. J. 330:1998;695-699.
31. Fleming I., Busse R. Signal transduction of eNOS activation. Cardiovasc. Res. 43:1999;532-541.
32. Mitsuyama T., Hidaka K., Furuno T., Hara N. Release of nitric oxide and expression of constitutive nitric oxide synthase of human endothelial cells: enhancement by a 14-membered ring macrolide. Mol. Cell. Biochem. 181:1998;157-161.
33. 2+ entry. J. Biol. Chem. 275:2000;17979-17985.
34. Parkinson S.J., Jovanovic A., Jovanovic S., Wagner F., Terzic A., Waldman S.A. Regulation of nitric oxide-responsive recombinant soluble guanylyl cyclase by calcium. Biochemistry. 38:1999;6441-6448.
35. Chen L.Y., Mehta J.L. Downregulation of nitric oxide synthase activity in human platelets by nitroglycerin and authentic nitric oxide. J. Investig. Med. 45:1997;69-74.
36. Grbovic L., Jovanovic A. Effect of the vascular endothelium on contractions induced by prostaglandin F2 alpha in isolated pregnant guinea pig uterine artery. Hum. Reprod. 11:1996;2041-2047.
37. Suzuki Y., Hattori T., Kajikuri J., Yamamoto T., Suzumori K., Itoh T. Reduced function of endothelial prostacyclin in human omental resistance arteries in pre-eclampsia. J. Physiol. 545:2002;269-277.
38. 2+ influx in stimulated endothelial cells and on endothelium-derived hyperpolarizing factor-mediated arterial hyperpolarization and relaxation. J. Cardiovasc. Pharmacol. 38:2001;130-140.
39. Bauersachs J., Popp R., Hecker M., Sauer E., Fleming I., Busse R. Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor. Circulation. 94:1996;3341-3347.